Sample analysis in structural biology often suffers from weak contrast in the transmission electron microscope (TEM). The KonTEM PhazR solves this contrast problem and thus enables scientists to extract more information about structure and function of cells on molecular level.
Exit since May 2014. Purchaser: FEI Company (NASDAQ: FEIC)
Profitable exit: KonTEM trade sale to FEI Company (NASDAQ: FEIC)
High-Tech Gründerfonds invests in KonTEM GmbH